Emerging at the UK, retatrutide, a novel molecule, is sparking considerable excitement within the healthcare community regarding its ability for physique control . This dual GIP and GLP-1 target agonist looks to offer a considerable benefit over established therapies, showing positive results in initial clinical trials . Researchers believe its … Read More